BioMarin to Participate in Three Investor Conferences in March

On March 2, 2023 BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) reported that management will participate in three upcoming investor conferences in March (Press release, BioMarin, MAR 2, 2023, View Source [SID1234628035]). Management will present at the Cowen Healthcare Conference on Wednesday, March 8th at 10:30am ET and at the Barclays Global Healthcare Conference on Wednesday, March 15th at 9:30am ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

For these conferences, that will be webcast live, please access by visiting BioMarin’s website at View Source A replay of the webcasts will be available for the events with presentations through the Company’s website for a limited time following the conferences.

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!